ACIU
AC Immune Ltd
2.70$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | +7,031.5% | -119.4% | – | -417.1% | – | – | – | – | – | – | |
| – | +1.1% | +0.2% | -1.4% | -3.5% | +0.0% | +15.7% | +1.8% | -1.6% | +6.0% | – | – | – | |
| – | +167.4% | +136.1% | -67.7% | +101.6% | -21.1% | +61.1% | -28.0% | -27.5% | +11.2% | – | – | – | |
| – | -3,540.2% | – | +403.7% | -126.5% | – | -110.3% | – | -106.5% | – | – | – | – | |
| – | -40.7% | +50.0% | -72.7% | +148.5% | -46.7% | +302.2% | +3.0% | -84.5% | +84.8% | -100.0% | – | – | |
| – | +393.2% | -201.2% | +221.8% | -97.2% | +83.3% | – | +688.7% | -13.6% | -22.7% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -0.6% | +48.0% | +0.8% | +1.2% | +0.8% | – | – | – | |
| – | +9,058.0% | -101.7% | -91.0% | +179.0% | +13.9% | +31.0% | -4.3% | +2.8% | +2.3% | – | – | – | |
| – | – | -146.1% | – | – | – | -522.9% | – | -65.0% | -141.0% | – | – | – | |
| – | – | – | +9,314.1% | -119.6% | – | -428.2% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.